Skip to content
★ Sign in to follow
LP
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€165k

Latest filing published 17 Sept 2013 for CME Group INC., €17k.

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

No signal scores available.

Laurent Paulhac: trading record in brief

Laurent Paulhac appears in our data through filings on CME Group Inc. shares, published by SEC (Form 4). We count 16 filings; the first trade dates from 15 September 2009 and the latest from 16 September 2013.

Sales make up the whole of the open-market record (2 sales, €165k). Outside the open market, there are 14 share grants.

The newest entry dates from 17 September 2013: a share grant of €17k, in CME Group Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Laurent Paulhac

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ◆
    Sr MD IR & OTC Prod & SvcsExecutivesCME Group Inc.
    23,080 USD0SEC
    319 shares@ US$72.35Common Stock Class ASEC:0001156375-13-000124:0
  • ◆
    Sr MD IR & OTC Prod & SvcsExecutivesCME Group Inc.
    26,697 USD0SEC
    369 shares@ US$72.35Common Stock Class ASEC:0001156375-13-000124:1
  • ◆
    Sr MD IR & OTC Prod & SvcsExecutivesCME Group Inc.
    27,710 USD0SEC
    383 shares@ US$72.35Common Stock Class ASEC:0001156375-13-000124:2
  • ◆
    Sr MD IR & OTC Prod & SvcsExecutivesCME Group Inc.
    34,439 USD0SEC
    476 shares@ US$72.35Common Stock Class ASEC:0001156375-13-000124:3
  • ◆
    Sr MD IR & OTC Prod & SvcsExecutivesCME Group Inc.
    0SEC
    3,048 shares0Common Stock Class ASEC:0001156375-13-000124:4
  • ◆
    Sr MD Fincl & OTC Prod & SvcsExecutivesCME Group Inc.
    10,166 USD0SEC
    161 shares@ US$63.14Common Stock Class ASEC:0001156375-13-000039:0
  • ◆
    Sr MD Fincl & OTC Prod & SvcsExecutivesCME Group Inc.
    0SEC
    1,752 shares0Common Stock Class ASEC:0001156375-13-000020:0
  • ▼
    Sr MD Fincl & OTC Prod & SvcsExecutivesCME Group Inc.
    154,325 USD0SEC
    2,585 shares@ US$59.70Common Stock Class ASEC:0001156375-12-000107:0
  • ▼
    Sr MD Fincl & OTC Prod & SvcsExecutivesCME Group Inc.
    59,720 USD0SEC
    1,000 shares@ US$59.72Common Stock Class ASEC:0001156375-12-000107:1
  • ◆
    Sr MD Fincl & OTC Prod & SvcsExecutivesCME Group Inc.
    0SEC
    3,716 shares0Common Stock Class ASEC:0001156375-12-000107:2
  • ◆
    Sr MD Fincl & OTC Prod & SvcsExecutivesCME Group Inc.
    23,026 USD0SEC
    391 shares@ US$58.89Common Stock Class ASEC:0001156375-12-000107:3
  • ◆
    Sr MD Fincl & OTC Prod & SvcsExecutivesCME Group Inc.
    22,084 USD0SEC
    375 shares@ US$58.89Common Stock Class ASEC:0001156375-12-000107:4
  • ◆
    Sr MD Fincl & OTC Prod & SvcsExecutivesCME Group Inc.
    29,563 USD0SEC
    502 shares@ US$58.89Common Stock Class ASEC:0001156375-12-000107:5
  • ◆
    MD OTC Products & ServicesExecutivesCME Group Inc.
    0SEC
    912 shares0Common Stock Class ASEC:0001156375-11-000116:0
  • ◆
    MD OTC Products & ServicesExecutivesCME Group Inc.
    0SEC
    1,212 shares0Common Stock Class ASEC:0001156375-10-000143:0
  • ◆
    MD OTC ProductsExecutivesCME Group Inc.
    0SEC
    828 shares0Common Stock Class ASEC:0001156375-09-000153:0

16 of 16 declarations